New hope for tough pancreatic tumors: pill boosts radiation power
NCT ID NCT06141031
Summary
This early-stage trial is testing whether adding an experimental pill called TTI-101 to a targeted form of radiation is safe and can better control pancreatic cancer. The study is for people whose pancreatic cancer is difficult to remove with surgery, even after initial chemotherapy. Researchers hope this combination will help keep the cancer from growing back for a longer period.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of Colorado
Aurora, Colorado, 80045, United States
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.